Sign in
4

Changes in Ownership

AIM ImmunoTech Inc. Filed Acc 0001450324-20-000007

Options or other derivatives

  • CEO acquired 300,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

EQUELS THOMAS K. · CEO

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-11-11 Grant or award : show line 1 in the form Options +300,000 300,000 D
Loading xslF345X03/primary_doc.xml…